Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome

Erik Rasmussen, Laura Cipp, Robert Hitzemann

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Previous studies have established that neuroleptic-induced catalepsy in mice is a highly heritable trait. The current study focuses on the detection of quantitative trait loci (QTL) for haloperidol-induced catalepsy in a BALB/cJ x LP/J F2 intercross. One thousand thirty-seven F2 animals were phenotyped and divided into four categories: very responsive (RR), responsive, nonresponsive, and very nonresponsive (NN). The RR and NN phenotypes comprised approximately 18% each of the total and differed in their haloperidol sensitivity by >10-fold. Sex differed significantly between the NN and RR groups (χ2 = 14.0; p <.0002); females comprised 58% of the RR individuals but only 38% of the NN individuals. The difference between the extreme phenotypes in the number of piebald animals was highly significant (χ2 = 30, p <.00001). Eight percent of the RR individuals were piebald compared with 30% of the NN individuals. A genome wide scan confirmed the presence of a QTL (peak LOD = 6.4) on chromosome 14 near the piebald (Ednrb) and 5-hydroxytryptamine(2A) (Htr2a) loci. Although the parental BALB/cJ and LP/J strains differed significantly in striatal 5-hydroxytryptamine(2A) receptor binding, no marked differences were detected between the phenotypic extremes. A second QTL was detected on chromosome 14 (peak LOD = 6.9), which was located more proximally and included the Chat locus. No QTLs were detected on chromosomes 1 and 9, thus differentiating this cross from previous results obtained for a C57BL/6J x DBA/2J intercross.

Original languageEnglish (US)
Pages (from-to)1337-1346
Number of pages10
JournalJournal of Pharmacology and Experimental Therapeutics
Volume290
Issue number3
StatePublished - Sep 1999
Externally publishedYes

Fingerprint

Catalepsy
Quantitative Trait Loci
Haloperidol
Chromosomes, Human, Pair 14
Chromosomes
Phenotype
Corpus Striatum
Chromosomes, Human, Pair 9
Serotonin Receptors
Chromosomes, Human, Pair 1
Antipsychotic Agents
Serotonin
Genome

ASJC Scopus subject areas

  • Pharmacology

Cite this

Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome. / Rasmussen, Erik; Cipp, Laura; Hitzemann, Robert.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 290, No. 3, 09.1999, p. 1337-1346.

Research output: Contribution to journalArticle

@article{bbf951c938574a80a8f7c6616ff044f3,
title = "Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome",
abstract = "Previous studies have established that neuroleptic-induced catalepsy in mice is a highly heritable trait. The current study focuses on the detection of quantitative trait loci (QTL) for haloperidol-induced catalepsy in a BALB/cJ x LP/J F2 intercross. One thousand thirty-seven F2 animals were phenotyped and divided into four categories: very responsive (RR), responsive, nonresponsive, and very nonresponsive (NN). The RR and NN phenotypes comprised approximately 18{\%} each of the total and differed in their haloperidol sensitivity by >10-fold. Sex differed significantly between the NN and RR groups (χ2 = 14.0; p <.0002); females comprised 58{\%} of the RR individuals but only 38{\%} of the NN individuals. The difference between the extreme phenotypes in the number of piebald animals was highly significant (χ2 = 30, p <.00001). Eight percent of the RR individuals were piebald compared with 30{\%} of the NN individuals. A genome wide scan confirmed the presence of a QTL (peak LOD = 6.4) on chromosome 14 near the piebald (Ednrb) and 5-hydroxytryptamine(2A) (Htr2a) loci. Although the parental BALB/cJ and LP/J strains differed significantly in striatal 5-hydroxytryptamine(2A) receptor binding, no marked differences were detected between the phenotypic extremes. A second QTL was detected on chromosome 14 (peak LOD = 6.9), which was located more proximally and included the Chat locus. No QTLs were detected on chromosomes 1 and 9, thus differentiating this cross from previous results obtained for a C57BL/6J x DBA/2J intercross.",
author = "Erik Rasmussen and Laura Cipp and Robert Hitzemann",
year = "1999",
month = "9",
language = "English (US)",
volume = "290",
pages = "1337--1346",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome

AU - Rasmussen, Erik

AU - Cipp, Laura

AU - Hitzemann, Robert

PY - 1999/9

Y1 - 1999/9

N2 - Previous studies have established that neuroleptic-induced catalepsy in mice is a highly heritable trait. The current study focuses on the detection of quantitative trait loci (QTL) for haloperidol-induced catalepsy in a BALB/cJ x LP/J F2 intercross. One thousand thirty-seven F2 animals were phenotyped and divided into four categories: very responsive (RR), responsive, nonresponsive, and very nonresponsive (NN). The RR and NN phenotypes comprised approximately 18% each of the total and differed in their haloperidol sensitivity by >10-fold. Sex differed significantly between the NN and RR groups (χ2 = 14.0; p <.0002); females comprised 58% of the RR individuals but only 38% of the NN individuals. The difference between the extreme phenotypes in the number of piebald animals was highly significant (χ2 = 30, p <.00001). Eight percent of the RR individuals were piebald compared with 30% of the NN individuals. A genome wide scan confirmed the presence of a QTL (peak LOD = 6.4) on chromosome 14 near the piebald (Ednrb) and 5-hydroxytryptamine(2A) (Htr2a) loci. Although the parental BALB/cJ and LP/J strains differed significantly in striatal 5-hydroxytryptamine(2A) receptor binding, no marked differences were detected between the phenotypic extremes. A second QTL was detected on chromosome 14 (peak LOD = 6.9), which was located more proximally and included the Chat locus. No QTLs were detected on chromosomes 1 and 9, thus differentiating this cross from previous results obtained for a C57BL/6J x DBA/2J intercross.

AB - Previous studies have established that neuroleptic-induced catalepsy in mice is a highly heritable trait. The current study focuses on the detection of quantitative trait loci (QTL) for haloperidol-induced catalepsy in a BALB/cJ x LP/J F2 intercross. One thousand thirty-seven F2 animals were phenotyped and divided into four categories: very responsive (RR), responsive, nonresponsive, and very nonresponsive (NN). The RR and NN phenotypes comprised approximately 18% each of the total and differed in their haloperidol sensitivity by >10-fold. Sex differed significantly between the NN and RR groups (χ2 = 14.0; p <.0002); females comprised 58% of the RR individuals but only 38% of the NN individuals. The difference between the extreme phenotypes in the number of piebald animals was highly significant (χ2 = 30, p <.00001). Eight percent of the RR individuals were piebald compared with 30% of the NN individuals. A genome wide scan confirmed the presence of a QTL (peak LOD = 6.4) on chromosome 14 near the piebald (Ednrb) and 5-hydroxytryptamine(2A) (Htr2a) loci. Although the parental BALB/cJ and LP/J strains differed significantly in striatal 5-hydroxytryptamine(2A) receptor binding, no marked differences were detected between the phenotypic extremes. A second QTL was detected on chromosome 14 (peak LOD = 6.9), which was located more proximally and included the Chat locus. No QTLs were detected on chromosomes 1 and 9, thus differentiating this cross from previous results obtained for a C57BL/6J x DBA/2J intercross.

UR - http://www.scopus.com/inward/record.url?scp=0032774210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032774210&partnerID=8YFLogxK

M3 - Article

C2 - 10454512

AN - SCOPUS:0032774210

VL - 290

SP - 1337

EP - 1346

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -